Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$24.27 USD
-0.43 (-1.74%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $24.33 +0.06 (0.25%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum C VGM
Anika Therapeutics (ANIK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$32.00 | $37.00 | $27.00 | 29.55% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Anika Therapeutics comes to $32.00. The forecasts range from a low of $27.00 to a high of $37.00. The average price target represents an increase of 29.55% from the last closing price of $24.70.
Analyst Price Targets (2 )
Broker Rating
Anika Therapeutics currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on two recommendations.
Of the two recommendations deriving the current ABR, one is Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
3/14/2024 | Stephens | George Sellers | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 2 |
Average Target Price | $32.00 |
LT Growth Rate | 10.00% |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | 0.30 |
ANIK FAQs
Anika Therapeutics Inc. (ANIK) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for Anika Therapeutics Inc. (ANIK) is $32.00. The current on short-term price targets is based on 2 reports.
The forecasts for Anika Therapeutics Inc. (ANIK) range from a low of $27 to a high of $37. The average price target represents a increase of $31.85 from the last closing price of $24.27.
The current UPSIDE for Anika Therapeutics Inc. (ANIK) is 31.85%
Based on short-term price targets offered by two analysts, the average price target for Anika Therapeutics comes to $32.00. The forecasts range from a low of $27.00 to a high of $37.00. The average price target represents an increase of 29.55% from the last closing price of $24.70.